A delay in getting to the rapid eye movement (REM) stage of sleep may be linked to Alzheimer's disease and related dementias, ...

SaveHealth provides an overview of Alzheimer's disease, including treatment and coping mechanisms for those with the disease ...

Drugs targeting amyloid plaques have failed to show efficacy in clinical trials. A new approach is needed to tackle AD ...

Alzheimer’s affects millions of Americans and can have a devastating impact on finances. Some of the worst damage is done before a diagnosis is even made.

The Alzheimer's Accountability and Investment Act (Public Law 118-93), enacted on October 1, 2024, mandates that the National ...

Revolutionary nasal spray offers hope by potentially delaying Alzheimer's progression through cutting-edge neurological ...

Alzheimer’s disease is currently the third-leading cause of death among seniors in the U.S., following cardiovascular disease ...

GlobalData epidemiologists forecast a rise in cases in the US from 2.97 million in 2024 to 4.06 million by 2033.

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

Anti-inflammatory drugs like ibuprofen, along with antibiotics, antiviral medications, and vaccines are associated with a ...

A study of rare familial genetic mutations linked to early-onset dementia supports the idea that stalled protein processing contributes to Alzheimer’s disease.

the top causes of death in the United States, have fallen sharply. But in an aging population, Alzheimer’s death rates have gone in the opposite direction. The disease afflicts nearly seven ...